Moleculin Biotech, Inc.
(NASDAQ:MBRX)
$0.60
0.02 (3.65%)
Open: 3:49 PM
MBRX Stock Price Graph
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- YTD
- All
MBRX Stock Price Today
Moleculin Biotech, Inc. (MBRX) stock rallied over 3.22% intraday to trade at $0.5987 a share on NASDAQ. The stock opened with a loss of -18.79% at $0.47 and touched an intraday high of $0.52, rising 3.22% against the last close of $0.58. The Moleculin Biotech, Inc. in stock market went to a low of $0.47 during the session.
MBRX Stock Snapshot
$0.58
Prev. Close
17.14 Million
Market Cap
$0.47
Day Low
$0.47
Open
N/A
Number of Shares
$0.52
Day High
N/A
P/E ratio
-0.90
EPS (TTM)
0.82
Cash Flow per Share
N/A
Free Float in %
1.18
Book Value
71417.00
Volume
MBRX Stock Price History Chart
| Date | Open | High | Low | Close | Volume |
|---|
Contact Details
Company Information
EmployeesN/A
Beta1.92
Sales or RevenueN/A
5Y Sales Change0.00%
Fiscal Year EndsDec. 2022
SectorHealthcare
IndustryBiotechnology
About Company
Moleculin Biotech, Inc., a clinical-stage pharmaceutical company, focuses on the development of drug candidates for the treatment of highly resistant tumors and viruses. Its lead drug candidate is Annamycin that is in Phase 1/2 studies for the treatment of relapsed or refractory acute myeloid leukemia (AML) and cancers metastasized to the lungs. The company's flagship immune/transcription modulator is WP1066, which is in Phase I clinical trial for the treatment of brain tumors and pediatric brain tumors, as well as pancreatic cancer and other malignancies. It also develops WP1220, an analog of WP1066 for the topical treatment of cutaneous T-cell lymphoma; and WP1122 to treat glioblastoma multiforme and COVID-19. The company has partnership and collaboration agreements with MD Anderson; Animal Life Sciences, LLC; and WPD Pharmaceuticals Sp z.o.o. Moleculin Biotech, Inc. was incorporated in 2015 and is headquartered in Houston, Texas.
Peers
Frequently Asked Questions
What is the current Moleculin Biotech, Inc. (MBRX) stock price?
Moleculin Biotech, Inc. (NASDAQ: MBRX) stock price is $0.60 in the last trading session. During the trading session, MBRX stock reached the peak price of $0.52 while $0.47 was the lowest point it dropped to. The percentage change in MBRX stock occurred in the recent session was 3.22% while the dollar amount for the price change in MBRX stock was $0.02.
MBRX's industry and sector of operation?
The NASDAQ listed MBRX is part of Biotechnology industry that operates in the broader Healthcare sector. Moleculin Biotech, Inc. , a clinical-stage pharmaceutical company, focuses on the development of drug candidates for the treatment of highly resistant tumors and viruses.
Who are the executives of MBRX?
Mr. Walter V. Klemp
Founder, Chairman, Pres & Chief Executive Officer
Mr. Jonathan P. Foster CPA
Executive Vice President & Chief Financial Officer
Mr. Walter V. Klemp
Founder, Chairman, Pres & CEO
Mr. Jonathan P. Foster CPA
Exec. VP & CFO
How MBRX did perform over past 52-week?
MBRX's closing price is 0.19% higher than its 52-week low of $0.338 where as its distance from 52-week high of $1.65 is -0.60%.
How many employees does MBRX have?
Number of MBRX employees currently stands at N/A. MBRX operates from 5300 Memorial Drive, Houston, TX 77007, US.
Link for MBRX official website?
Official Website of MBRX is: https://www.moleculin.com
How do I contact MBRX?
MBRX could be contacted at phone #713 300 5160 and can also be accessed through its website. MBRX operates from 5300 Memorial Drive, Houston, TX 77007, US.
How many shares of MBRX are traded daily?
MBRX stock volume for the day was 71417.00 shares. The average number of MBRX shares traded daily for last 3 months was 157 Thousands.
What is the market cap of MBRX currently?
The market value of MBRX currently stands at $17.14 Million with its latest stock price at $0.60 and N/A of its shares outstanding.